Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Eli Lilly
Eli Lilly
FDA guidelines consider amyloid reduction 'reasonably likely' to predict Alzheimer's benefit
Fierce Biotech
Tue, 03/12/24 - 11:34 am
Biogen
Eisai
Aduhelm
FDA
Alzheimer's disease
amyloid
Eli Lilly
donanemab
To boldly go back: Lilly charts 2nd space trip in 4 months, this time with chronic disease tests
Fierce Biotech
Tue, 03/12/24 - 11:17 am
Eli Lilly
chronic disease
drug discovery
Lilly's lebrikizumab, delayed at FDA, clears eczema in people with skin of color
Fierce Biotech
Mon, 03/11/24 - 05:11 pm
Eli Lilly
eczema
lebrikizumab
FDA
Setbacks reset views on highly touted Alzheimer's and ALS drugs
Axios
Mon, 03/11/24 - 05:06 pm
Alzheimer's disease
ALS
Amylyx
Relyvrio
Eli Lilly
donanemab
Lilly’s Donanemab Hit with Surprise Delay, Set to Face FDA Adcomm
BioSpace
Fri, 03/8/24 - 11:55 am
Eli Lilly
FDA
Alzheimer's disease
donanemab
Banning WuXi is more complicated than it might sound
Stat
Thu, 03/7/24 - 11:32 am
China
legislation
WuXi
Eli Lilly
drug manufacturing
Where’s Lilly’s Alzheimer’s approval?
Stat
Tue, 03/5/24 - 11:08 am
Eli Lilly
donanemab
Alzheimer's disease
Eli Lilly could launch obesity drug in India next year, CEO says
Reuters
Wed, 02/28/24 - 11:05 am
Eli Lilly
Mounjaro
India
Why is pharma going gaga for radiopharmaceuticals?
Pharmaphorum
Tue, 02/27/24 - 11:19 am
radiopharmaceuticals
oncology
Novartis
Eli Lilly
Bristol Myers Squibb
Weight-loss drugs could boost US GDP by 1% in coming years, Goldman says
Reuters
Thu, 02/22/24 - 11:14 pm
obesity
weight loss
GLP-1 agonist
Novo Nordisk
Eli Lilly
Novo Nordisk, Eli Lilly lead industrywide sales surge in Q4
Fierce Pharma
Thu, 02/22/24 - 11:12 pm
earnings
Novo Nordisk
Eli Lilly
obesity
Eli Lilly Has More Than an Ozempic Competitor -- Much More
Motley Fool
Wed, 02/21/24 - 11:14 am
Eli Lilly
obesity
cancer
diabetes
psoriasis
Alzheimer's disease
Lilly Edges Out J&J to Top 20 BioPharma Market Cap List for 2023
BioSpace
Tue, 02/20/24 - 05:55 pm
market cap
Eli Lilly
JNJ
Novo Nordisk
After migraine accord with Eli Lilly, Organon CEO scouts more deals to bolster growth
Fierce Pharma
Fri, 02/16/24 - 11:45 am
Organon
Eli Lilly
Emgality
Britain sees launch of Lilly's weight-loss drug Mounjaro
Reuters
Wed, 02/14/24 - 11:31 am
Eli Lilly
Mounjaro
weight loss
UK
3 questions hanging over the Novo-Catalent deal
Pharma Voice
Wed, 02/14/24 - 10:55 am
Novo Nordisk
Catalent
drug manufacturing
Ozempic Wegovy
Eli Lilly
Eli Lilly partner BioAge raises $170 mln for obesity treatment
Reuters
Tue, 02/13/24 - 11:24 am
BioAge Labs
Eli Lilly
obesity
funding
COVID-19 Cliff and Skyrocketing GLP-1 Drug Sales Highlight Q4 2023 Earnings
BioSpace
Sun, 02/11/24 - 03:50 pm
earnings
COVID-19
GLP-1 agonist
JNJ
Bristol Myers Squibb
Pfizer
AstraZeneca
Sanofi
Eli Lilly
Novo Nordisk
New weight-loss drugs linked to lower risk of depression: study
Axios
Fri, 02/9/24 - 11:12 am
depression
weight loss
Novo Nordisk
Eli Lilly
Ozempic
Wegovy
Mounjaro
Here's Why Merck, Eli Lilly, and Novo Nordisk Stocks Rose 11% Last Month
Motley Fool
Thu, 02/8/24 - 10:01 pm
Merck
Eli Lilly
Novo Nordisk
weight loss
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »